|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Recurrent Metastatic Breast CarcinomaFrom: Gautam Allahbadia (drallah@homeindia.com)Sun Mar 15 01:02:25 1998
Medical Summary Mrs. ABC was first seen at the Tata Memorial Hospital, Bombay on 18.5.92 with complaints of lump in the left breast. She was investigated and diagnosed as a case of carcinoma left breast and underwent left modified radical mastectomy on 26.5.92. The histopathological review of the specimen revealed a 2 x 1.5 cm tumour (IDC grade II). All 16 axillary nodes dissected were negative for metastasis. Post-operatively she was started on adjuvant chemotherapy – Tamoxifen 10 mg bd which was stopped in 1995. In July 1997 she presented with hoarseness of voice. A CT scan of thorax and abdomen done on 3.11.97 showed a soft tissue mass in antero-superior mediastinum encasing the left subclavian and the left common carotid artery with caudal extension upto the level of aortic arch. She was posted for palliative radiation therapy and was found to be in good general condition with Karnofsky performance score of 90%. There was no evidence of peripheral lymphadenopathy or organomegaly. Locally there was no evidence of disease over the left chest wall. Haematological examination did not reveal any abnormality. Bone scan done on 8.1.97 showed multiple areas of increased tracer uptake. X-ray cervical and lumbosacral spine done on 25.11.97 was suggestive of cervical spondylosis. She received 2 cycles of Inj. Taxotere + Carboplatin on 12.11.97 and 4.12.97. She received palliative radiation therapy to the mediastinum with 6MV photons with AP/PA portals to a dose of 30 Gy/15fr/32 days followed by localised boost with right & left anterior oblique ports to a dose of 26 Gy/14fr/28 days thus delivering a total cumulative dose of 56 gGy/29 fr/53 days from 8.12.97 to 30.1.98. Radiotherapy was tolerated well with moderate symptomatic improvements, with a bout of chemotherapy induced neutropenia which was managed using colony stimulating factor (Neupogen). Third course of chemotherapy (Taxotere + Carboplatin) was given on 10.2.98 & the 4th course was given on 5.3.98. She has been advised two more similar courses at intervals of three weeks. Following completion of the above, she will be re-evaluated. I would really like a second-opinion, suggestions, advise & will be grateful for the same.
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:27:24 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.